<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:mp ids='MP_0001845'>Inflammation</z:mp> and <z:mpath ids='MPATH_3'>apoptosis</z:mpath> play an important role in cerebral ischemic pathogenesis and may represent a target for treatment </plain></SENT>
<SENT sid="1" pm="."><plain>Silibinin has been proved to elicit a variety of biological effects through its anti-inflammatory and anti-apoptotic properties in hepatotoxic, <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> and carcinogenic events </plain></SENT>
<SENT sid="2" pm="."><plain>Whether this protective effect applies to ischemic injury in brain is still unknown, we therefore investigated the potential protective role of silibinin in <z:hpo ids='HP_0002140'>ischemic stroke</z:hpo> and the underlying mechanisms </plain></SENT>
<SENT sid="3" pm="."><plain>Silibinin was administered intragastric 30 min before permanent middle cerebral <z:mp ids='MP_0006134'>artery occlusion</z:mp> (pMCAO) </plain></SENT>
<SENT sid="4" pm="."><plain>We found that silibinin significantly alleviated neurological deficit, reduced <z:mpath ids='MPATH_124'>infarct</z:mpath> volume, and suppressed <z:hpo ids='HP_0002181'>brain edema</z:hpo>, which were accompanied with upregulation of pAkt, pmTOR, HIF-1α, Bcl-2 and downregulation of Bax, NF-κB in ischemic brain tissue after <z:hpo ids='HP_0001297'>stroke</z:hpo> </plain></SENT>
<SENT sid="5" pm="."><plain>Our results show that silibinin might exert anti-inflammatory and anti-apoptotic effects in ischemic brain through activating Akt/mTOR signaling </plain></SENT>
</text></document>